PPARG and breast carcinoma: Moreover, the ω-3 PUFA docosahexaenoic acid (DHA) acting as an agonist of PPARγ stimulates apoptosis in breast cancer cells increasing the expression of the tumor suppressor syndecan-1 (SDC-1) [26].